PHIA Koninklijke Philips N.V.

Children’s Hospital of Georgia uses Philips’ automated early detection and warning solution to improve pediatric patient deterioration response

Children’s Hospital of Georgia uses Philips’ automated early detection and warning solution to improve pediatric patient deterioration response

March 25, 2020

  • Predictive analytics help reduce early warning scoring inaccuracies by 75%*
  • Gauge variables & automatically calculate patient scores, increasing emergency response team interventions by 80%* for critical patients while mitigating false escalations

Amsterdam, the Netherlands and Augusta, GA, U.S. (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Children’s Hospital of Georgia has adopted Philips’ automated early detection and warning solution () for pediatrics. This scalable solution, which could be comprised of a combination of patient monitoring, telehealth, predictive analytics software and services, enables quick identification of signals of clinical patient deterioration and triggers a warning notification to the hospital staff allowing faster response times.

With the implementation of the Philips system, Children’s** saw a 75%* decrease in pediatric early warning scoring (PEWS) inaccuracies on its pediatric medicine floor and was able to eliminate inaccuracies on its pediatric surgery floor. In addition, the Pediatric Medicine floor saw an 80%* increase in pediatric emergency response team escalations, allowing clinical teams to provide timely, critical interventions for patients in need. Children’s is part of Augusta University Health, a forward-thinking health system that was the first in North America to sign a 15-year, long-term strategic partnership with Philips.

In the U.S. each year, approximately 76% of pediatric patients have identifiable respiratory or cardiac deterioration one hour prior to arrest [1].  The Philips system, which leverages intelligent algorithms and predictive analytics, automates scoring and aids clinicians in identifying patients at risk, leading to timely interventions, optimized rapid response escalations and better patient care and outcomes. While PEWS systems can help determine whether early interventions are necessary, manual data entry for calculations, including subjective measurements, can make it difficult for hospital staff to account for variabilities in a patient’s age and development, potentially leading to inaccuracies.

“We have seen an increase in the number of patients with complex medical conditions admitted to Children’s but most patient monitoring systems that detect deterioration are built for adults and can’t account for pediatric patients, resulting in more data entry demands on our staff,” said Renuka Mehta, pediatric intensivist at Children’s Hospital of Georgia. “The implementation of this solution has automated the process of identifying at-risk patients with improved accuracy, enabling our staff to address potential issues as early as possible, which makes for a better experience for our staff and potential better outcomes for our patients. This also allows the team to spend more time at the bedside caring for our patients and their families.”

Philips’ automated early detection and warning solution to detect patient deterioration () simplifies workflow and automates some steps in patient rounding and assessments as well as frequently trending vitals and other key information to identify at-risk patients. It allows for critical notifications to be directly delivered to the care team’s (mobile) devices, even when on the go. The interoperable solution natively integrates with Children’s Philips patient monitoring systems, sends validated patient data directly to the EMR and the admission, discharge, and transfer (ADT) system. By automating this process and eliminating labor-intensive manual tasks, Children’s PEWS can be used with minimized opportunities for error and increased opportunities for early intervention, while also giving health care professionals more time to spend with patients.

“Not only has Augusta University Health pioneered long-term strategic partnerships here in the U.S., they have worked closely with us to push the boundaries of health care – from same-day diagnosing and treatment of lung cancer in the hybrid operating room, to improving workflows as part of Children’s new design,” said , Chief Philips North America, member of the Executive Committee Royal Philips. “The implementation of Philips’ automated early detection and warning solution at Children’s is another example of their commitment to providing breakthrough, family-centered care, while ensuring the best possible working environment for their staff.”

Philips has a broad portfolio of patient monitoring, telehealth, predictive analytics solutions and services for care providers and patients at home. For more information on Philips’ full portfolio of integrated smart enterprise systems, devices, software and services, visit the Philips HIMSS virtual experience at  and follow for #VirtualHIMSS20 updates.

[1] Buist, M. D., Moore, G. E., Bernard, S. A., Waxman, B. P., Anderson, J. N., & Nguyen, T. V. (2002). Effects of a medical emergency team on reduction of incidence of and mortality from unexpected cardiac arrests in hospital: preliminary study. BMJ (Clinical research ed.), 324(7334), 387–390. /10.1136/bmj.324.7334.387

*Unit: 4CMC – Pediatrics Medicine Measurement period: 7 months. This data is exclusive to Children’s Hospital of Georgia.

**Results from case studies are not predictive of results in other cases. Results in other cases may vary.

For further information, please contact:

Silvie Casanova

Philips North America

Tel:

Email:

Kathy O’Reilly

Philips Global Press Office

Tel:

Email:

Twitter:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

About Children’s Hospital of Georgia

The not-for-profit Children’s Hospital of Georgia is Augusta’s only children's hospital and the pediatric teaching affiliate of the Medical College of Georgia. For more than 100 years, Children’s has provided the highest level of neonatal and pediatric intensive care, including air and ground transportation for critically ill babies and children, a 24/7 emergency department staffed by fellowship-trained pediatric emergency and trauma specialists, couplet care for high-risk moms and babies, and pediatric heart surgery and specialists. The Children’s Hospital of Georgia recently earned the highest ranking in pediatric quality and safety among more than 100 of the nation’s leading academic medical centers.

 

Attachments

EN
25/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation ...

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...

 PRESS RELEASE

Philips reiterates timing of 2026 outlook

Philips reiterates timing of 2026 outlook December 4, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company’s previously communicated schedule. As previously guided, the company expects continued performance improvement with sequential comparable sales growth, expanded margins (despite tariff headwinds) and strong cashflow. The company continues to expect comparative sales growth to accelerate sequentially in 2026 towards mid-single-digit gro...

 PRESS RELEASE

Philips expands commercial availability of world’s first real-time AI-...

Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy December 1, 2025 Commercial availability expanded across Europe and the United StatesReal-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex endovascular proceduresLumiGuide seamlessly integrates with Azurion, Philips’ proven, world-leading image-guided therapy platform designed to drive procedural innovation across clinical domains Amsterdam, the Netherlands and Chicago, USA – (NYSE: PHG, AEX: PH...

 PRESS RELEASE

Philips launches Verida, world’s first detector-based spectral CT powe...

Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4] Amsterdam, the Netherlands and Chicago, USA – At RSNA 2025, (NYSE: PHG, AEX: PHIA), a global leader in health techno...

 PRESS RELEASE

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MR...

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled BlueSeal Horizon [1], an entirely new 3.0T MRI innovation platform that includes the industry’s first helium-free 3.0T magnet at . A pivotal advance in MRI innovation, helium-free [2] 3.0T is a major scientific achievement set to have s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch